Atlantis Consumer Healthcare Inc., headquartered in the United States, is a prominent player in the consumer healthcare industry, specialising in innovative over-the-counter products. Founded in 2010, the company has rapidly expanded its operational reach across North America and Europe, establishing a strong market presence. Renowned for its flagship brand, Betadine, Atlantis Consumer Healthcare offers a unique range of antiseptic solutions that stand out for their efficacy and safety. The company’s commitment to quality and consumer trust has led to significant milestones, including numerous industry awards and recognitions. With a focus on research and development, Atlantis continues to enhance its product offerings, solidifying its position as a leader in the healthcare sector.
How does Atlantis Consumer Healthcare Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Atlantis Consumer Healthcare Inc's score of 21 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Atlantis Consumer Healthcare Inc, headquartered in the US, currently does not have specific carbon emissions data available for reporting. As a current subsidiary, it inherits its climate commitments and emissions data from its parent organisation, which is not specified in the provided information. The company has not outlined any specific reduction targets or initiatives, nor does it appear to have set Science-Based Targets Initiative (SBTi) commitments. Without concrete emissions figures or reduction strategies, it is challenging to assess Atlantis Consumer Healthcare Inc's overall climate impact or commitments. In the broader context of the industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting ambitious targets to mitigate their environmental footprint. However, without specific data or commitments from Atlantis Consumer Healthcare Inc, it remains unclear how the company aligns with these industry trends.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 8,000 |
| Scope 2 | 15,000 |
| Scope 3 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Atlantis Consumer Healthcare Inc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

